1369 |
What's the Final Goal of Transcatheter Renal Denervation? |
David E. Kandzari |
May. 14. 12 |
1368 |
What We\'ve Learned from Simplicity HTN-1,2, and Registries |
Horst Sievert |
May. 14. 12 |
1367 |
Best Preparation for Prevention of Stroke in CAS |
Michael R. Jaff |
May. 14. 12 |
1366 |
Doppler Analysis During CAS in Symptomatic Patients |
Jae-Hwan Lee |
May. 14. 12 |
1365 |
Proximal Protection vs. Distal Protection in CAS |
William A. Gray |
May. 14. 12 |
1364 |
Stroke Risk and Its Etiology During CAS |
Issam D. Moussa |
May. 14. 12 |
1363 |
How to Manage of Complication Related PCI for CTO |
Toshiya Muramatsu |
May. 14. 12 |
1362 |
Changes of Strategy and Outcomes for CTO in Europe |
Nicolaus J. Reifart |
May. 14. 12 |
1361 |
Antegrade or Retrograde Approach: Best Way and Best Decision ? |
Nae-Hee Lee |
May. 14. 12 |
1360 |
When I Am Stuck in the CTO Path, How Can I Solve the Problem ? |
Yasushi Asakura |
May. 14. 12 |